Kilitch Drugs Faces Investor Sentiment Shift Amid Declining Trading Activity
Kilitch Drugs (India) Ltd has faced notable trading activity, hitting its lower circuit limit with a significant decline in stock price. The company has underperformed its sector recently, with a marked decrease in trading volume and delivery participation, indicating shifting investor sentiment amid a challenging market environment.
Kilitch Drugs (India) Ltd, operating in the Pharmaceuticals & Biotechnology sector, has experienced significant activity today as the stock hit its lower circuit limit. The last traded price stood at Rs 421.5, reflecting a decline of Rs 16.8 or 3.83%. The stock reached an intraday low of Rs 416.4, marking a 5% decrease from the previous close.In terms of trading volume, approximately 0.05997 lakh shares were exchanged, resulting in a turnover of Rs 0.2513 crore. The stock has been on a downward trend, underperforming its sector by 4.41% and recording a total decline of 14.11% over the past three days. Notably, the weighted average price indicates that more volume was traded closer to the low price, suggesting a shift in investor sentiment.
Despite being above the 50-day, 100-day, and 200-day moving averages, Kilitch Drugs is currently below its 5-day and 20-day moving averages. The delivery volume has also seen a decline of 23.67% compared to the 5-day average, indicating falling investor participation. Overall, Kilitch Drugs continues to navigate a challenging market environment, reflecting broader trends within the microcap segment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
